SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-003854
Filing Date
2023-03-02
Accepted
2023-03-02 17:04:45
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 form4-03022023_100328.html 4  
1 form4-03022023_100328.xml 4 7279
  Complete submission text file 0001415889-23-003854.txt   8575
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Reents Scott T (Reporting) CIK: 0001937048 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 23700148